Accordingly, the BDNF level was also significantly upregulated in the scopolamine-induced Alzheimer’s disease (AD) model of adult mouse brains following the TASE and thymol treatments in our previous report [17]. This evidence concerns the gene BDNF and early-onset autosomal dominant Alzheimer disease.